SOC 313 Week 4 Quiz
Question 1
pts
Match the following terms and definitions.
Exploratory surgery used for diagnosing tissue where the surgeon removes
tissue so it can be determined whether the tissue is malignant
biopsy
A mass of abnormal cells in the body; can be benign or malignant
tumor
The spread of cancer from one part of the body to another
metastasis
The process of describing whether a cancer has spread and, if so, how far;
uses the tumor, node, metastasis (TNM) system
staging
A branch of medicine that focuses on the treatment of cancer
Oncology
PartialQuestion 2
pts
Match the following terms and definitions.
Diagnostic test results that incorrectly identify a healthy person as having a medical
disorder, such as cancer
false positive
Diagnostic test results that fail to detect the presence of a medical disorder, such as
cancer
false negative
The increased or decreased likelihood of disease when two independent risk or
prevention factors reinforce one another resulting in a higher or lower probability that if
the variables were independent of each other
interaction effect
Controlled experiment that studies a new therapy alongside a standard therapy
clinical trials
,Experimental design ensuring that subjects are randomly placed in a treatment group.
Neither the researchers nor the study participants know the group to which they are
assigned
double-blind study
Question 3
pts
Match the following terms and definitions.
A legal document that states what kind of medical treatment the patient wants at the
end of life and who can make healthcare decisions for the patient if the patient is not
able to do so
advance directive or living will
A legal document that allows a patient to name a person as their proxy, or agent, to
make, communicate, and maintain control over healthcare decisions for them if or when
they are no longer able to do so for themselves because of a health condition
medical power of attorney
A document created for a cancer patient and their primary care physician that
summarizes the patient's diagnosis and treatment during the acute phase of the illness as
well as the recommended plan for follow-up treatment and surveillance
survivorship care plan
A characteristic, either genetic, behavioral, or environmental, that decreases the risk of
developing cancer
protective factor
Monitoring of a therapy's effects in a larger patient population, once the drug or
treatment is on the market, with the goal of detecting any issues not uncovered during
smaller-scale clinical trials
post-marketing surveillance
Question 4
pts
Simon’s brain cancer is not responding to treatment, and his cancer team is concerned
that his mental abilities will deteriorate. How should they address this concern?
Contact a therapist to help them convince Simon to transition to palliative care.
Develop a medication therapy for dealing with Simon’s mental issues.
Talk with Simon and his family about preparing a living will.
Let Simon know they are ceasing the painful treatments.
, Question 5
pts
Sarah is collecting data related to cancer rates. The data covers three
decades of people in a single zip code located adjacent to a power plant.
Sarah’s goal is to see if there is any pattern between cancer rates and the
plant’s activities. Which of the following terms best describes what Sarah is
studying?
The Bradford Hill criteria
Epidemiology
Epidemiological transition
The interaction effect
Question 6
pts
Katherine has stage-four ovarian cancer and doesn’t seem to be responding
to treatment. Her doctor tells her he could try to get her into a double-blind
clinical trial for an experimental therapy. What is a potential risk for
Katherine to consider?
If she is in the control group, she might not get any treatment at all.
Since the therapy is still in clinical trial, there is a high likelihood it isn’t
effective.
There may be side effects to the experimental treatment that are harmful.
If her doctor knows she is in the control group, he might not be as invested
in her care.
Question 7
pts
Which of the following is NOT a reason researchers have attributed to the
rarity of SCPs in cancer care?
Oncologists are not reimbursed for preparing SPCs by health insurance
companies.
Oncologists tend not to see any benefit to SCPs.
Question 1
pts
Match the following terms and definitions.
Exploratory surgery used for diagnosing tissue where the surgeon removes
tissue so it can be determined whether the tissue is malignant
biopsy
A mass of abnormal cells in the body; can be benign or malignant
tumor
The spread of cancer from one part of the body to another
metastasis
The process of describing whether a cancer has spread and, if so, how far;
uses the tumor, node, metastasis (TNM) system
staging
A branch of medicine that focuses on the treatment of cancer
Oncology
PartialQuestion 2
pts
Match the following terms and definitions.
Diagnostic test results that incorrectly identify a healthy person as having a medical
disorder, such as cancer
false positive
Diagnostic test results that fail to detect the presence of a medical disorder, such as
cancer
false negative
The increased or decreased likelihood of disease when two independent risk or
prevention factors reinforce one another resulting in a higher or lower probability that if
the variables were independent of each other
interaction effect
Controlled experiment that studies a new therapy alongside a standard therapy
clinical trials
,Experimental design ensuring that subjects are randomly placed in a treatment group.
Neither the researchers nor the study participants know the group to which they are
assigned
double-blind study
Question 3
pts
Match the following terms and definitions.
A legal document that states what kind of medical treatment the patient wants at the
end of life and who can make healthcare decisions for the patient if the patient is not
able to do so
advance directive or living will
A legal document that allows a patient to name a person as their proxy, or agent, to
make, communicate, and maintain control over healthcare decisions for them if or when
they are no longer able to do so for themselves because of a health condition
medical power of attorney
A document created for a cancer patient and their primary care physician that
summarizes the patient's diagnosis and treatment during the acute phase of the illness as
well as the recommended plan for follow-up treatment and surveillance
survivorship care plan
A characteristic, either genetic, behavioral, or environmental, that decreases the risk of
developing cancer
protective factor
Monitoring of a therapy's effects in a larger patient population, once the drug or
treatment is on the market, with the goal of detecting any issues not uncovered during
smaller-scale clinical trials
post-marketing surveillance
Question 4
pts
Simon’s brain cancer is not responding to treatment, and his cancer team is concerned
that his mental abilities will deteriorate. How should they address this concern?
Contact a therapist to help them convince Simon to transition to palliative care.
Develop a medication therapy for dealing with Simon’s mental issues.
Talk with Simon and his family about preparing a living will.
Let Simon know they are ceasing the painful treatments.
, Question 5
pts
Sarah is collecting data related to cancer rates. The data covers three
decades of people in a single zip code located adjacent to a power plant.
Sarah’s goal is to see if there is any pattern between cancer rates and the
plant’s activities. Which of the following terms best describes what Sarah is
studying?
The Bradford Hill criteria
Epidemiology
Epidemiological transition
The interaction effect
Question 6
pts
Katherine has stage-four ovarian cancer and doesn’t seem to be responding
to treatment. Her doctor tells her he could try to get her into a double-blind
clinical trial for an experimental therapy. What is a potential risk for
Katherine to consider?
If she is in the control group, she might not get any treatment at all.
Since the therapy is still in clinical trial, there is a high likelihood it isn’t
effective.
There may be side effects to the experimental treatment that are harmful.
If her doctor knows she is in the control group, he might not be as invested
in her care.
Question 7
pts
Which of the following is NOT a reason researchers have attributed to the
rarity of SCPs in cancer care?
Oncologists are not reimbursed for preparing SPCs by health insurance
companies.
Oncologists tend not to see any benefit to SCPs.
